Drugs / DDP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05232552 Background | Jan 2021 → Dec 2022 | nasopharyngeal carcinoma | Zhejiang Cancer Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DDP | “docetaxel 75mg/m2 d1 plus DDP 75mg/m2 d1 for 3 cycles every 21days” NCT05232552 ↗ |